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Abstract
Background: Understanding of the transmission dynamics of tuberculosis (TB) in high TB and HIV prevalent
settings is required in order to develop effective intervention strategies for TB control. However, there are little data
assessing incidence of TB infection in adolescents in these settings.
Methods: We performed a tuberculin skin test (TST) and HIV survey among secondary school learners in a high
HIV and TB prevalence community. TST responses to purified protein derivative RT23 were read after 3 days. HIV-
infection was assessed using Orasure
® collection device and ELISA testing. The results of the HIV-uninfected
participants were combined with those from previous surveys among primary school learners in the same
community, and force of TB infection was calculated by age.
Results: The age of 820 secondary school participants ranged from 13 to 22 years. 159 participants had
participated in the primary school surveys. At a 10 mm cut-off, prevalence of TB infection among HIV-uninfected
and first time participants, was 54% (n = 334/620). HIV prevalence was 5% (n = 40/816). HIV infection was not
significantly associated with TST positivity (p = 0.07). In the combined survey dataset, TB prevalence was 45% (n =
645/1451), and was associated with increasing age and male gender. Force of infection increased with age, from
3% to 7.3% in adolescents ≥20 years of age.
Conclusions: We show a high force of infection among adolescents, positively associated with increasing age. We
postulate this is due to increased social contact with infectious TB cases. Control of the TB epidemic in this setting
will require reducing the force of infection.
Background
Tuberculosis (TB) remains a major cause of morbidity
and mortality in the world[1]. In order to develop effec-
tive intervention strategies for TB control, it is impor-
tant to understand TB transmission in high burden
settings. While there have been recent studies assessing
TB infection in young children[2-5], there are few data
assessing TB infection in older children and adolescents
in communities with high TB and HIV burdens[6].
Incidence of TB infection is a measure of current trans-
mission in a community. While repeated testing of
uninfected individuals over time is a conventional
method for determining incidence of a disease, this
methodology is both labour and time intensive, and is
further complicated by the boosting of the immune
response in immunology-based tests such as the tubercu-
lin skin test (TST)[7,8]. Therefore alternative approaches
for calculating incidence from prevalence data have been
developed. The annual risk of TB infection (ARTI), cal-
culated from TB infection prevalence data, is an averaged
m e a s u r eo fr i s ko fT Bi n f e c t i o no v e rt h el i f e t i m eo ft h e
study participants[7,9]. The limitation of this measure is
that ARTI only provides an estimate of current transmis-
sion or incidence if calculated in very young participants.
In comparison, force of infection, defined as the propor-
tion of susceptible individuals that have become infected
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can be calculated using changes in age-specific preva-
lence rates[10-12], and provides an estimate of recent
infection incidence across a wider age range.
This approach is a relatively new concept that has
been utilized to estimate incidence in diseases in which
true incidence is difficult or costly to measure, such as
glaucoma[13] and more recently, HIV[12,14]. The math-
ematical techniques utilized are based on the principle
that prevalence is a function of incidence and duration
of illness or infectivity[15]. This principle holds true
under the assumptions of disease stability. Data from
this community suggest that TB transmission has
remained relatively constant over the past decade, as
evidenced by the stable TB notification rates among
HIV-uninfected adults from 1997 to 2008[16], as well as
the stable childhood TB over the same time period[2].
We performed a TST survey among adolescents in a
high HIV and TB prevalence community to assess pre-
valence of TB infection and force of infection by age.
Methods
This study was the third in a series of cross-sectional
tuberculin skin testing surveys performed among
school-attending children in the study community. The
first two surveys were performed in the local primary
school in 2006 and 2007[2]. The survey reported in this
manuscript was performed in children attending second-
ary school in the study community in 2009. The same
methodology was used in all three surveys, with the
addition of HIV testing in the secondary school survey.
Children were eligible if they were resident in the com-
munity and registered at the local secondary school.
Parental consent, and assent from participants <18 years
of age, were obtained prior to enrolment. Adolescents
≥18 years of age provided written consent. Basic demo-
graphic information was collected and participants were
examined for the presence of a BCG scar. Participants
received the TST regardless of BCG scar status.
The WHO-recommended standard Mantoux test of
2TU of PPD (Purified Protein Derivative) RT23 with
Tween 80 (Statens Seruminstitut, Copenhagen) was
administered intradermally to the volar surface of the
left forearm by a trained nurse. The tuberculin reaction
size was read by a trained assessor three days following
the inoculation. The presence or absence of a reaction
was noted, and, where present, the size of the induration
was measured along perpendicular axes using standard
calipers. Participants also provided an oral transudate
specimen for HIV testing, using the Orasure
® collection
device and Vironostika Uni-Form II HIV-1 and HIV-2
plus 0 ELISA test (bioMérieux SA, Marcy l’Etoile,
France). HIV results were anonymous but linked to TST
results and all adolescents were encouraged to have
separate voluntary counseling and testing at local facil-
i t i e s .H I Vt e s t i n gw a sn o tp e r f o r m e di nt h ep r i m a r y
school surveys[2].
This study was approved by the University of Cape
Town’s Research Ethics Committee. All children with a
TST reaction ≥10 mm were recalled for investigation for
active tuberculosis and referred to the local clinic for
further management if appropriate.
Data were analyzed using STATA 9.0 (StataCorp, Col-
lege Station, Texas). Analysis was performed in two
parts: firstly on the secondary school dataset, excluding
HIV-infected individuals, and secondly on the secondary
school dataset combined with the primary school dataset,
excluding the HIV-infected individuals from the second-
ary school survey. Children who declined HIV testing
were considered to be HIV-uninfected for the purposes
of the TB analysis.
TST results were calculated as the mean of the two dia-
meters of the TST reaction: a positive reaction was defined
at 10 mm cut-off, based on clinical guidelines[17,18].
ARTI was calculated as 1-(1-prevalence)
1/(mean age+0.5)[19].
As the age in full years at participants’ last birthday was
used, 0.5 was added to the mean age for the calculation of
ARTI[19]. The secondary school sample was divided into
age quartiles and TB prevalence and ARTI were calculated
overall and for each age group. Bivariate analyses
employed Student’st - ,F i s h e r ’s exact and Wilcoxon sum
rank tests, as appropriate. Multiple logistic regression
models were developed to examine factors associated with
positive TST results.
HIV data secondary school participants
Univariate and multivariate logistic regression models
were developed to determine the demographic charac-
teristics associated with HIV, and to assess for an asso-
ciation between HIV and TB infection. In these models,
a TST reaction size of ≥5 mm was used as a positive
cut-off for TB infection in HIV-infected adolescents, in
keeping with clinical guidelines[17,18].
Subset of repeat TST participants
Overall, 159 students who had participated in the 2007
survey also took part in the secondary school survey,
resulting in repeat tuberculin testing of these partici-
pants. Repeated TST tests may be associated with boost-
ing of the immune response, complicating the
interpretation of the second TST reaction size[7,8]. We,
therefore, analyzed this subset of participants separately
from the rest of the cohort. In keeping with existing lit-
erature, we defined a true conversion to TST positivity
between the two surveys as a change from a negative
result (<10 mm) on original TST to a positive result
(≥10 mm) on the second test, with an absolute reaction
size increase of at least 6 mm[20-22]. Bivariate analyses
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priate for comparison of participants with repeated TST
compared to first time participants in 2009. A multivari-
ate regression model was developed to compare reaction
sizes between the two groups. The McNemar test was
used for matched comparison of 2007 and 2009 TST
results.
Combined surveys database
In order to assess the effect of age on TB prevalence
and force of infection, we combined the primary and
secondary survey datasets, excluding HIV-infected parti-
c i p a n t sf r o m2 0 0 9 ,a sw e l la st h es e c o n dt e s ti nt h o s e
participants who had repeat tests in 2009. The partici-
pants were divided into age quartiles and TB prevalence
and ARTI were calculated overall and for each age
group.
Smoothed prevalence of TB infection by age was cal-
culated from predictive logistic regression models on
the combined primary and secondary school dataset,
overall and stratified by gender, excluding those who
tested HIV-infected in the secondary school. Force of
infection was calculated at specific ages for the pool of
individuals who remained uninfected [annual change in
prevalence/(1-prevalence)]. Trends in ARTI and force of
infection were assessed using Cox-Stuart test for trend
[23,24].
For all analysis, 95% confidence intervals (CI) were
based on the Poisson distribution and all statistical tests
were 2-sided at alpha = 0.05.
Results
Of the 959 children enrolled in the secondary school,
839 were eligible for study participation (87%). Ineligibil-
ity was due to residence outside of the community (n =
80) or having dropped out of school (n = 40). Consent/
assent was obtained for 820 children (98% of those eligi-
ble). Refusal by parent or learner accounted for 18 non-
consenters and 1 child was not consented due to absen-
teeism over the study period. All 820 consented students
were enrolled. Four of the children enrolled declined
tuberculin skin testing, and four children declined HIV
testing. Of the 816 children who underwent skin testing,
813 (99.6%) had the TST reaction read within 72-96
hours (Figure 1). No study-related adverse events were
noted in the three children assessed outside the window
period and these participants were excluded from the
analysis.
Table 1 shows the demographic characteristics of the
secondary school study cohort. Of the 813 participants
who completed TST testing, 159 had received tuberculin
skin testing in the 2007 survey in the community. These
participants were excluded from the main analysis and
their results are presented in a sub-analysis. Of the
remaining 654 children, all but three of the participants
underwent HIV testing. In total 34 participants of the
remaining participants tested HIV-infected, and were
excluded from the TB analysis (n = 620; Figure 1).
Among the 620 participants, ages ranged from 13 to
22 years, with a mean age of 17.5 years, and 59% of par-
ticipants were female. The majority of the children did
not have a BCG scar (87%); one child’s BCG scar status
was not recorded, and this participant was excluded
from analysis involving BCG scar status.
TST reaction sizes ranged from 0 to 30 mm (median
= 11.5 mm; IQR: 0-16.5 mm), and 222 children had a
TST result of 0 mm (36%). The frequency distribution
of reaction sizes >0 mm are presented in Figure 2.
There was no significant difference between the median
size of reactions in participants with BCG scars com-
pared to those without scars (11 vs 11.5 mm respec-
tively, p = 0.24).
At the 10 mm cut-off 334 participants (54%) had a
positive TST result. There was no significant difference
in the defined TB positivity by BCG scar status (p =
0.99). In a multivariate logistic regression model predict-
ing the relative odds of a positive TST result, age was
positively associated with a positive TST result (adjusted
odds ratio (OR) for a 1-year increase in age: 1.10, 95%
CI: 1.01 - 1.21; p = 0.03), as was male gender (adjusted
OR for female compared to male: 0.65, 95% CI: 0.47-
0.90; p = 0.01).
The overall ARTI for this sample was 4.2% (95% CI:
3.8-4.7%). Table 2 reportsT Bp r e v a l e n c ea n dA R T I
overall, and by age quartiles. The ARTI did not differ
significantly across the age quartiles (p = 0.75) or across
age by years from 14 to 21 years of age (p = 0.63).
Sub-analysis: HIV and TB infection
Of the 820 participants enrolled in the secondary school
survey, 816 (99.5%) consented to HIV testing. In total
40 (4.9%) participants tested HIV-positive. In a logistic
regression model, HIV infection was associated with
increasing age (OR: 1.3; 95% CI: 1.1-1.6; p = 0.001) and
female gender (OR: 2.3; 95% CI: 1.1-4.7; p = 0.03).
Among the 809 participants who underwent both TST
and HIV testing, 38 were HIV-infected, four of whom
had previous TST testing in 2007. The median TST
reaction size among HIV-infected participants (amongst
those who did not have repeat TST assessment; n = 34)
was smaller than that of HIV-uninfected participants (0
vs 11.5 mm; p = 0.08), and this difference was signifi-
cant when adjusted for age and gender (p = 0.04). Using
the revised cut-off of ≥5 mm, 15 (40%) HIV-infected
participants were TST positive. In a multivariate logistic
regression model adjusted for age and gender, HIV
infection was not significantly associated with TST posi-
tivity (OR = 0.53; 95% CI: 0.27-1.05; p = 0.07).
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Table 1 Demographic characteristics of the secondary school sample.
First time TST participants
F Repeat TST participants
FF
HIV-uninfected HIV-infected Total HIV-uninfected HIV-infected Total
n = 617 n = 34 n = 654 n = 154 n = 4 n = 159
n (%) n (%) n (%) n (%) n (%) n (%)
Age: mean (range) 17.5 (13-22) 18.4 (15-22) 17.5 (13-22) 15.4 (13-19) 15.3 (14-17) 15.4 (13-19)
13-16 yrs 176 (29) 5 (15) 183 (28) 133 (86) 3 (75) 136 (86)
17 yrs 148 (24) 4 (12) 152 (23) 13 (8) 1 (25) 15 (9)
18 yrs 112 (18) 9 (26) 121 (19) 6 (4) 0 (0) 6 (4)
19-22 yrs 181 (29) 16 (47) 202 (30) 2 (1) 0 (0) 2 (1)
Gender: Male 255 (41) 9 (34) 266 (41) 81 (53) 2 (50) 84 (53)
BCG Scar present 80 (13) 6 (18) 86* (13) 32 (21) 0 (0) 32 (20)
TST positive 331 (54) 11 (32) 345 (53) 90 (58) 1 (25) 91 (57)
*n = 653: one participant’s BCG scar status was not recorded
F Three participants declined HIV testing
FFOne participant declined HIV testing
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In 2009, 159 students who had participated in the 2007
survey took part in the secondary school survey, four of
whom were HIV-infected. The mean reaction size in
2009 among participants with repeat tests was larger
compared to participants who tested for the first time
(15 vs 11.5 mm; p < 0.001), and this finding persisted
when adjusted for age and gender (p < 0.001). Overall,
TB prevalence did not differ between those that had a
repeat TST test and those participants who were testing
for the first time (58 vs 54%, p = 0.29).
Using a 10 mm cut-off for positivity, in 2007, 76 (48%)
of the 159 participants had a positive TST result; in
2009 91 (57%) tested TST positive. Overall, 19 of the 83
participants who were TST negative in 2007 tested posi-
tive in 2009 (p = 0.003), and four (5%) reverted to a
TST negative result. Using the definition outlined above,
18 of the 19 convertors had an increase in reaction size
of ≥6 mm and were therefore considered true new
infections with TB. These 18 participants, from the pool
of 83 susceptible children in 2007, equate to an inci-
dence of 22% over two years (95 CI: 13-32%), or an
annual incidence of infection of 11% ([18/83]/2).
Combined Primary and Secondary school database
In order to assess the effect of age on TB prevalence and
force of infection, we investigated combining the primary
and secondary school surveys. We compared the preva-
lence of TST positive results for the three cohorts in the
overlapping age ranges of 10 to 12 years and 14 to 16
years. The chi-squared test for comparison was not sig-
nificant (survey 1 and 2: p = 0.66; survey 2 and 3: p =
0.46), nor was survey year a significant risk factor in mul-
tivariate regression model for TST positivity (p = 0.23).
Therefore we combined these two datasets. In the pri-
mary school survey, TST readings were available for 831
of the 832 children enrolled. Therefore the combined
database, excluding the participants who tested HIV-
infected, was comprised of 1,451 participants.
Ages of the combined cohort ranged from 5 to 22 years,
with a mean age of 13.6 years (standard deviation = 4.1),
and 52% of participants were female. The majority of the
children did not have a BCG scar (80%); BCG scar status
was not available for two participants and they were there-
fore excluded from analysis involving BCG scar status.
TST reaction sizes ranged from 0 to 30 mm (mean =
8.0; median = 0 mm). Overall 728 (50%) of the participants
had no reaction to the TST. At the 10 mm cut-off 645
participants (45%) had a positive TST result (Table 3). TB
prevalence by age is presented in Figure 3. In a multivari-
ate logistic regression model a positive TST result was sig-
nificantly associated with age (adjusted OR for a 1-year
increase in age: 1.17, 95% CI: 1.10 - 1.25; p < 0.001) and
male gender (adjusted OR for female compared to male:
0.74, 95% CI: 0.60-0.92; p = 0.01). TST positivity was not
associated with BCG scar status (p = 0.40).
Table 4 reports the smoothed prevalence of TB infec-
tion by age, as predicted by our logistic regression
model. Also reported in Table 4 are the ARTI and force
of infection by age, calculated from the smoothed preva-
lence. The overall ARTI for this sample was 4.1% (95%
CI: 3.8-4.4%). The ARTI did not differ significantly
across age by years from 6 to 22 years of age (p = 0.15).
The force of infection increased with increasing age, and
this trend was significant (p = 0.01).
Discussion
This is one of the first studies to report TB infection
prevalence, ARTI and force of infection in adolescents
in a high TB and HIV prevalent setting.
Figure 2 Frequency distribution of TST reactions (>0 mm) in
HIV-uninfected participants in secondary school survey.
Table 2 Secondary school TB prevalence and ARTI by age
quartile for the 10 mm cut-off point (excluding HIV-
infected and repeat TST participants):
Age
Category
Mean
Age*
n
(%)
TST
positive
Prevalence ARTI%
(95% CI)
13-16 yrs 15.8 178
(29)
85 47.8% 4.0%
(3.2-5.0%)
17 yrs 17.5 148
(24)
76 51.4% 4.0%
(3.2-5.0%)
18 yrs 18.5 112
(18)
58 51.8% 3.9%
(2.9-5.0%)
19-22 yrs 20.2 182
(29)
115 63.2% 4.8%
(4.0-5.8%)
TOTAL 18 620 334 53.9% 4.2%
(3.8-4.7%)
* The mean age reported here is the age used for the ARTI calculations, and
is based on the mean age for the age category+0.5 years, as described in the
methods section.
Note: Participants who declined HIV testing were presumed to be HIV-
uninfected and were included in the TB analysis
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reported in the primary school children[2], and show a
high force of infection. ARTI provides a measure of the
averaged risk of infection over the participants’ lifetime.
Therefore this measure pertains to the annual risk over
a period of up to 20 years, and consequently the ARTI
provides little informationo nt h ec u r r e n tt r a n s m i s s i o n
within the study population.
Force of infection is a measure of recent transmission
and the high rates reported here are in keeping with the
substantial burden of TB prevalence[25] and notifica-
tions[26] in this community and in South Africa[1]. We
demonstrated that force of infection was positively asso-
ciated with increasing age. These findings are consistent
with those reported prior to the HIV epidemic[27], as
well as by more recent mathematical modeling[6]. The
advantage that this study had over the modeling paper
is that of greater numbers of older adolescent partici-
pants all recruited from the same community, and the
ability to show that the force of infection continues to
increase up to approximately 20 years of age. In adult-
hood force of infection becomes harder to measure due
to a reduced proportion of susceptible individuals, and
the inability to identify secondary infections.
Force of infection is a function of the probability of
an effective encounter with an infectious TB case, and
as such is a product of TB disease prevalence and mix-
ing patterns. We postulate that the association between
f o r c eo fi n f e c t i o na n da g em a yb ed u et oi n c r e a s i n g
social mixing patterns, resulting from changing social
interactions associated with age. We have previously
shown that TB infection in primary school children is
associated with an adult TB case on their residential
plot[28], while TB transmission between adults is due
to social interactions off the residential plots[6]. Data
from Europe shows that number of social contacts
peak in adolescents[29], suggesting that the likelihood
of contact with infectious persons may also peak at
this time. The social interactions, and therefore risk of
TB infection, of mid-teens may more closely resemble
that of adults rather than younger children in the
community.
We have also shown a changing risk of TB infection
by gender: in the primary school surveys, gender was
not associated with TB infection[2], but in the secondary
school survey, male gender was associated with
increased TB infection. As males get older, their risk of
TB infection out-strips that of females of similar age,
and this is consistent with other reports in the literature
[9,21]. This increased risk may be due to a combination
of increased biological susceptibility, differing immuno-
logical responses or differences in socialization patterns
of male compared to female adolescents.
The lack of association between HIV and TB infection
is a key finding: adolescents infected with HIV did not
appear to be at higher risk for acquiring primary TB
infection. This is in keeping with findings reported from
lower HIV and TB prevalent settings[30,31], and consis-
tent with studies that suggest the establishment of TB
infection is mechanistic, as opposed to immune-based
[32]. However, adolescents are at increased risk of pro-
gression to TB disease in the first two years following TB
Table 3 TB prevalence and ARTI by age quartile for the
10 mm cut-off point for the three surveys combined
(excluding HIV-infected and second tests in repeat TST
participants):
Age
Category
Mean
Age*
n
(%)
TST
positive
Prevalence ARTI%
(95% CI)
Age
Category
5-9 yrs 8.3 325
(22)
91 28.0% 3.9%
(3.1-4.7%)
10-14 yrs 12.8 488
(34)
207 42.4% 4.0%
(3.2-5.0%)
15-17 yrs 16.7 344
(24)
174 50.6% 3.9%
(2.9-5.0%)
18-22 yrs 19.6 294
(20)
173 58.8% 4.8%
(4.0-5.8%)
Gender
Male 13.8 691
(48)
330 47.8% 4.6%
(4.1-5.1%)
Female 14.3 760
(52)
315 41.4% 3.7%
(3.3-4.1%)
TOTAL 14.1 1,451 645 44.5% 4.1%
(3.8-4.4%)
* The mean age reported here is the age used for the ARTI calculations, and
is based on the mean age for the age category+0.5 years, as described in the
methods section.
Note: Participants who declined HIV testing were presumed to be HIV-
uninfected and were included in the TB analysis
Figure 3 TB prevalence in combined dataset, by age (in years).
Note: This figure is based on the unadjusted data presented in
Table 3.
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nity place adolescents at substantial risk of TB disease.
The high incidence rate of TB infection in the subset of
participants tested 2 years apart, confirms the high force
of infection. However, due to the boosting of the immune
response with enhanced allergy noted with repeated
TSTs[8,34-38], the incident rate in this subset is higher
than the force of infection. This is highlighted by the lar-
ger median TST reaction sizes in participants with a
repeat test compared to first time participants. Similarly,
reduced and anergic responses to TST have been noted
in HIV-infected patients[39-42], as evidenced by the
smaller median reaction sizes in HIV-infected partici-
pants compared to HIV-uninfected participants. These
two scenarios highlight a limitation of using an immune-
based test for determining TB infection.
Only 20% of the children in this study had an observa-
ble BCG scar, despite the South African policy to vacci-
nate all infants with the BCG vaccine[43]. However
BCG scarring may be variable[38,44] and we found no
difference in the distribution of TST results between
those children with or without BCG scars.
In this study, only 1% of TST results were weakly
positive (1 to 5 mm), suggesting minimal cross reaction
with environmental mycobacteria[19]. Given the high
TB prevalence in the sample, the positive predictive
value of the TST is likely to be high.
HIV testing was not performed in the primary school
surveys. However, the Actuarial Society of South Africa
(ASSA) 2003 AIDS and Demographic model for the
African population[45,46] reports an HIV prevalence of
<4% in this age group. Therefore HIV is unlikely to
have substantially impacted TST readings in this group
and, given the anergic reactions to TST associated with
HIV[39-42], any impact of HIV is likely to result in an
underestimate of TB infection. We were able to exclude
HIV-infected children from the secondary school TB
analysis, thereby reducing the potential bias resulting
from dual infections.
This study had a very low refusal rate (<4% across all
three surveys), and as such volunteerism is unlikely to
have biased our results. However, it should be noted
that the school-attending children may not be represen-
tative of all the children in the community, in particular
with regards to risk of HIV infection[47,48]. However,
should either HIV or TB infection be higher among
non-school attending children, this would result in an
underestimation of the prevalence and force of TB
infection in this study.
The high force of infection in this community would
result in significant rates of primary and secondary TB
infection and, given the high HIV prevalence among
adults[6], and the considerable increased risk of progres-
sion to TB disease in HIV-infected individuals[30,49],
Table 4 Predicted prevalence, ARTI and force of infection by age in study cohort
Age Number of participants Predicted Prevalence*
(95% CI)
ARTI** Force of infection
F
5 1 0.22 (0.17 - 0.27) 4.85
6 36 0.24 (0.19 - 0.29) 4.47 2.93
7 84 0.26 (0.22 - 0.30) 4.21 3.15
8 112 0.28 (0.24 - 0.32) 4.06 3.39
9 92 0.31 (0.27 - 0.34) 3.96 3.81
10 71 0.33 (0.29 - 0.36) 3.91 3.96
11 59 0.35 (0.32 - 0.39) 3.89 4.28
12 107 0.38 (0.35 - 0.41) 3.91 4.47
13 135 0.41 (0.38 - 0.43) 3.93 5.03
14 116 0.43 (0.41 - 0.46) 3.97 5.11
15 84 0.46 (0.44 - 0.49) 4.04 5.58
16 106 0.49 (0.46 - 0.52) 4.10 5.70
17 154 0.52 (0.48 - 0.55) 4.18 6.05
18 112 0.54 (0.51 - 0.58) 4.27 6.44
19 101 0.57 (0.53 - 0.61) 4.36 6.63
20 46 0.60 (0.55 - 0.64) 4.45 7.11
21 21 0.62 (0.58 - 0.67) 4.55 7.37
22 14 0.65 (0.60 - 0.70) 4.66 7.34
* Predictive logistic regression model: logit{P(Age)} = -1.82+0.111 age.
** The ARTI calculations are based on the mean age for the age category+0.5 years, as described in the methods section.
F Force of infection = annual change in prevalence/(1-prevalence)
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TB disease in this setting. Control of the TB epidemic
requires an increasing proportion of non-infected indivi-
duals in a population, in other words, a decreased force
of infection[50]. In order to reduce the force of infec-
tion, National Tuberculosis Programmes need to
decrease the prevalence of infectious cases in the com-
munity. We have previously shown that a high coverage
antiretroviral treatment (ART) program will reduce TB
prevalence among HIV-infected participants, due to
both improved immune function and the active TB
case-finding among patients initiating ART[25]. Extend-
ing active case finding to HIV-uninfected residents may
substantially reduce the burden of infectious cases.
Social programs, such as improved housing, that impact
the environment in which individuals interact may also
lead to a reduction in the incidence of TB infection.
Conclusions
In conclusion, these data suggest a substantial force of
infection among adolescents, which is associated with
increasing age. This is most likely due to changing social
mixing patterns among adolescents, resulting in
increased contact with infectious TB cases. Studies into
social interaction patterns at different ages in this setting
may help to better understand this increasing risk of TB
infection. HIV infection was not associated with
increased risk of TB infection. However, the extremely
high force of infection, together with the high commu-
nity HIV prevalence, explains the overwhelming burden
of TB disease in this township. Control of the TB epi-
demic will require reducing the force of infection, and
further studies assessing intervention strategies such as
those suggested here are required.
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